Traxion Sab De Cv Ord Shs GRPOF

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I don't own shares. but I think this helps TBP

[Chuck03]

You do spew fake news: you said recently that no trials at all were ongoing, like an angry child shouting something as they exit a room.

gkmackdadzzz1 wrote:

SmokinAces wrote: Glad you asked, I thought i might not have been clear. You are correct, 1 $ million average for past 3 months. But, 150,000$ is the cost to keep the lights on per month when trials are completed. I factored in an additional 25 - 50 million$ required to finish ongoing (not trials in pre-dev stages) trials ontop of the cash burn rate.  In short, Tetra Bio-Pharma is looking at 2 x its current share float by late - 2020. Subsequently, It wont matter as much, if trials are successful. But yes, current overall burn rate is 1$ million per month and is likely to increase by next financials to 1.5 $ million per month for ongoing trials.     

at least from your statement above i can see you've give it some thought as to the risk involved and punctuated with "if trials are successful".  furthermore, you can acknoweldge that signifcant dilution to come is highly probabl and the guys like leafy stating things like "2$ by jan" just don't get it.

btw...i don't think they even own lights, that they need to pay to keep on.  the opex is doubled in with R$D and payrolls and it's hard to distinguish what R$D includes if it doesnt include 400k in salaries for 3 months.

unfortunately, you're right i have a bias here, but with the exception of people calling me a "moron" and saying i'm "spewing fake news" when im just stating things from TBPs document....it's not a personal biased grudge. anyway, good to luck to you man.